Polku Therapeutics Revenue
Biotechnology Research • 
Finland • 1-10 Employees
$
Polku Therapeutics revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | $2,000,000 |
Key Contact at Polku Therapeutics
Milla Koistinaho
Member Board of Directors
Company overview
| Headquarters | Finland |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Polku Therapeutics Email Formats
Polku Therapeutics uses 2 email formats. The most common is {first name} (e.g., john@polku-therapeutics.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@polku-therapeutics.com | 66.7% |
{first initial} | j@polku-therapeutics.com | 33.3% |
About Polku Therapeutics
Polku Therapeutics Oy is carving a new path to a healthy aging brain by developing innovative, disease-modifying therapies for neurodegenerative diseases. By targeting key pathways involved in protein aggregation and neuroinflammation, Polku aims to deliver breakthrough treatments for conditions such as Parkinson's Disease, Alzheimer’s, and frontotemporal dementia.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Australia
United States
United Kingdom
Germany
Frequently asked questions
Polku Therapeutics is located in FI.
Polku Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.
Polku Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Polku Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Polku Therapeutics has raised a total of $2,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
